Efficacy of Curcumin in Oral Submucous Fibrosis

• Status: Unknown status
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine whether the formulations of curcumin will effect the clinical signs and symptoms and histopathological features in patients with clinical stage 2 oral submucous fibrosis (OSMF).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: H.K.E.S's S.Nijalingappa Institute of Dental Science and Research
• Treatments: Curcumin

Criteria

Inclusion Criteria:

• 200 clinical stage 2 OSMF patients

Exclusion Criteria:

• Clinical stage 1 & 3 OSMF patients, oromucosal disorders with clinical features same as OSMF, patients who are under treatment, clinically diagnosed cases not ready for incisional biopsy, patients suffering from medically compromised conditions.